Clinical Trial Update: An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating an AI-powered precision immunotherapy approach for rheumatoid arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Prof Salvatore Albani | Conditions: Rheumatoid Arthritis (RA), Rheumatology | Phase 2 | Status: RECRUITING